AMN Healthcare price target raised to $24 from $20 at Truist

Truist raised the firm’s price target on AMN Healthcare (AMN) to $24 from $20 and keeps a Buy rating on the shares as part of a broader research note on Human Capital names. The firm notes that it does not expect winter orders to meaningfully improve Nurse and Allied segment trends, but also views these orders as a signal of improving demand trends in the travel nurse business, the analyst tells investors in a research note, adding that historically, AMN has assisted major customers with labor disruptions.